Clinical Trial Update: Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

View source ↗

Summary

A clinical trial update describing a study of breast cancer risk in women who are BRCA1 or BRCA2 mutation carriers. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: brca1 Mutation Carrier, brca2 Mutation Carrier | Status: UNKNOWN